Clinical Trial Update: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 pilot trial evaluating an investigational neuromodulation device for acute migraine attacks in children and adolescents has completed and posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Neuromodulation device for acute migraine (investigational)

Snippet

Sponsor: University of Calgary | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2025-03-12